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Abstract 
Our objective was to determine the effects of calcium salts of long-chain fatty 
acids (CLFA) and rumen-protected methionine (RPM) on plasma concentrations of 
ghrelin, glucagon-like peptide-1 (7-36) amide (GLP-1) and pancreatic hormones in 
lactating cows.  Four midlactation Holstein cows were used in a 4 x 4 Latin square 
experiment in each 2-wk periods.  Cows were fed corn silage-based diets with 
supplements of CLFA (1.5% added on dry matter basis), RPM (20 g/d), CLFA plus 
RPM and without supplement.  Jugular blood samples were taken from 1 h before to 2 
h after morning feeding at 10 min intervals on day 12 of each period.  CLFA decreased 
DMI, but RPM did not affect DMI.  Both supplements of CLFA and RPM did not 
affect metabolizable energy intake and milk yield and composition.  Plasma NEFA, 
triglyceride (TG) and total cholesterol (T-Cho) concentrations were increased with 
CLFA alone, but increases of plasma TG and T-Cho concentrations were moderated by 
CLFA plus RPM.  CLFA increased plasma ghrelin concentration and the ghrelin 
concentration with CLFA plus RPM was the highest among the treatments.  Plasma 
GLP-1, glucagon and insulin concentrations were decreased with CLFA, whereas 
adding RPM moderated the decrease of plasma glucagon concentration by CLFA.  
These results suggest that the addition of Met to cows given CLFA increases plasma 
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ghrelin and glucagon concentrations associated with the decrease in plasma TG and 
T-Cho concentrations. 
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1. Introduction 
Fat supplementation in diets for milk production is valid to increase dietary 
energy density [1].  However, increasing the dietary fat content often depresses DMI of 
lactating cows [2].  The mechanism of hypophagia induced by fat supplementation is 
incompletely understood and assumed to be affected by various factors involving the 
absorption process and metabolism of fatty acids.  Methionine (Met) improves lipid 
metabolism [3] partially by altering the activities of hormone-sensitive lipase and 
lipoprotein lipase [4].  In dairy cows, Met is the first limiting amino acid for milk 
production [5].  Supplementation of Met hydroxyl analog increases milk fat synthesis 
with hypertriglycemia [6].  Conversely, an insufficiency of Met during the 
periparturient period results in the development of hepatic lipidosis [7].  These reports 
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suggest that Met may affect lipid metabolism in dairy cows.  In lactating ewes, 
supplementation of rumen-protected Met (RPM) combined with fat increased DMI, 
milk yield and milk fat secretion compared with the supplementation of fat only [8], but 
the effects of Met on plasma metabolite and hormone concentrations were unknown.  
Recently Relling and Reynolds [9, 10] reported changes in plasma concentrations of 
some gut hormones such as glucagon-like peptide-1 (7-36) amide (GLP-1) and ghrelin 
caused by several nutrients in lactating cows, partly because of their role in the 
regulation of feed intake.  Additionally, these gut hormones were reported to influence 
insulin and glucagon secretion [11, 12].  Therefore, in this study we evaluated the 
effects of adding calcium salts of long-chain fatty acids (CLFA) and RPM on plasma 
metabolite and hormone concentrations in lactating cows. 
 
 
2. Materials and Methods 
 
The procedures used in the present study were carried out in accordance with the 
principles and guidelines for animal use issued by the National Institute of Livestock 
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and Grassland Science Animal Care Committee, and which were formulated to comply 
with Japanese regulations. 
 
Animals and Management  
One primiparous and three multiparous Holstein cows (143.5 ± 3.9 d in milk, 
calving number: 1.75 ± 0.25, initial body weight: 547.3 ± 14.7 kg) were fed four diets 
formulated to meet the nutrient requirements according to the Japanese Feeding 
Standard for Dairy Cattle [13].  The ingredients and composition of the diets are 
presented in Table 1.  The cows were managed in individual tie stalls, allowed free 
access to water, and provided experimental diets twice daily at 0900 and 1800 h.  They 
were milked twice daily before each feeding (0840 and 1740 h), and weighed every 
week.  
 
Treatments and Experimental Design 
The cows were used in a 4 × 4 Latin square design in each 2-wk period.  Four 
treatments consist of basal diet only (without supplement), supplemented with CLFA 
made from palm and soybean oil [Megalac R (Church & Dwight Co., Inc., Princeton, 
NJ, USA)], with RPM [Lactet SP (Nippon Soda Co., Ltd., Tokyo, Japan)], and with 
Table 1 
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CLFA plus RPM.  The CLFA containing 85% fatty acids was added to 1.5% of the diet 
DM, following a previous study [14].  The RPM containing 67% of D-, L-Met was 
supplemented at 20 g/d for RPM or CLFA plus RPM treatment.  Cows were offered 
each diet ad libitum, allowing for 15% refusal for the first 10 d for each treatment.  For 
the last 4 d of each period, the cows were fed 95% of ad libitum intake for estimating 
metabolizable energy intake (MEI).  Refusals were weighed daily before each morning 
feeding (0800 h). 
 
Sampling 
     Samples of the diets and the refusals were collected and pooled for the last 4 d of 
each period.  Milk samples were collected for the last 4 d of each period, added with 
sodium azide as preservative, and stored at 4℃ until analysis.  Blood samples were 
taken at 12 d from the jugular vein catheter (Argyle 14 G CV catheter kit; Nippon 
Sherwood Medical Industries Ltd., Tokyo, Japan) inserted on 10 d of each period.  
Blood samples (8 mL) were taken at 10 min intervals from 0800 to 1100 h.  Cows 
were milked during bleeding period (-20 and -10 min sampling time), and they were fed 
just after 0 min sampling.  Blood samples were collected into heparinized tubes with 
aprotinin [500 kilo inhibitor unit (KIU) /mL of blood; Trasylol, Bayer Leverkusen, 
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Germany], and centrifuged at 1,500 × g for 20 min at 4℃.  Harvested plasma samples 
were stored at -80℃ until assay. 
 
Sample Analysis 
     The diet samples and refusals were analysed for DM, CP, NDF, crude fat and 
crude ash contents according to the procedures of AOAC (1990) [15].  Metabolizable 
energy contents in the treatment diets were calculated based on NRC (2001) [1]. 
Milk samples were measured for fat, protein, lactose, TS and SNF by infrared 
analysis (Milko-Scan 1344 A/BN.; Foss Electric Company, Inc., Hillerod, Denmark). 
Plasma ghrelin, insulin and GLP-1 concentrations were measured every 10 min 
by time-resolved fluoro-immunoassay (TR-FIA). 
Assay for bioactive ghrelin was conducted as described previously [16].  Ghrelin 
concentration was measured by competitive solid-phase immunoassay using europium 
(Eu)-labeled synthetic bovine ghrelin and polystyrene microtiter strips (Nalge Nunc Int., 
Tokyo, Japan) coated with anti-rabbit γ-globulin.  Intra- and inter-assay coefficients of 
variation were 1.3 and 1.5%, respectively.  Least detectable dose and 50% inhibitory 
concentration in this assay system were 0.025 and 0.831 ng/mL, respectively.  
Insulin assay was conducted as described previously [17].  Insulin concentration 
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was measured by competitive solid-phase immunoassay using Eu-labeled synthetic 
bovine insulin and polystyrene microtiter strips coated with anti-guinea pig γ-globulin.  
Intra- and inter-assay coefficients of variation were 2.2 and 1.8%, respectively.  Least 
detectable dose and 50% inhibitory concentration in this assay system were 0.016 and 
1.073 ng/mL, respectively. 
GLP-1 concentration was measured by competitive solid-phase immunoassay 
based on the method described by Sugino et al. [16] using rat GLP-1 (Peptide Institute, 
Inc., Osaka, Japan), Eu-labeled rat GLP-1, polystyrene microtiter strips coated with 
anti-rabbit γ-globulin and anti-human GLP-1 rabbit serum (1:20,000; Yanaihara Institute 
Inc., Shizuoka, Japan).  Intra- and inter-assay of coefficients of variation were 1.7 and 
4.8%, respectively.  Least detectable dose and 50% inhibitory concentration in this 
assay system were 0.024 and 0.172 ng/mL, respectively.  
Plasma glucagon levels were measured every 20 min using a commercially 
available RIA kit (glucagon assay kit, Daiichi Radioisotope Co. Ltd., Tokyo, Japan).  
Glucagon concentrations were measured in the same assay, and the intra-assay 
coefficient of variation was 3.4%.  Least detectable dose and 50% inhibitory 
concentration in this assay system were 15.6 and 275 pg/mL, respectively. 
Plasma glucose concentrations were determined every 10 min using a glucose 
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analyzer (GA-1151; Arkray Co, Ltd., Kyoto, Japan).  Plasma β-hydroxy butyrate 
(BHBA), NEFA, triglyceride (TG), total-cholesterol (T-Cho) and urea nitrogen (UN) 
concentrations were determined every 20 min using an automated biochemistry analyzer 
(Beckman Coulter, Inc., Tokyo, Japan). 
 
Statistics 
Data for feed intake, milk yield, milk composition and plasma amino acid 
concentrations were analyzed using the MIXED procedure of SAS (SAS Institute, Inc., 
Cary, NC, USA).  The mixed model included treatment as a fixed effect, and cow and 
period as random effects.  For the statistical analysis of plasma hormone and 
metabolite concentration, sampling time and sampling time × treatment were added to 
the model.  Factorial contrasts were used to test the main effects of CLFA 
supplementation (CLFA vs. non-CLFA), RPM supplementation (RPM vs. non-RPM), 
and their interaction.  Results are reported as least squares means and SEM.  
Significant differences were set at P < 0.05.  
 
 
3. Results 
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Feed Intake, Milk Yield, and Milk Composition 
     DMI, milk yield and milk composition are presented in Table 2.  DMI in cows 
fed CLFA diets compared with cows fed non-CLFA diets was lower (P = 0.025), 
whereas MEI was not affected.  There was no significant effect of RPM on DMI and 
MEI.  Milk yield and composition, except for total solid contents, were unaffected by 
CLFA and RPM.  Milk total solid contents tended to be lower in cows fed CLFA diets 
compared with cows fed non-CLFA diets (P = 0.107).  
 
Plasma Concentration of Hormones and Metabolites 
     The changes in plasma concentration of hormones and metabolites are presented 
in Figures 1 and 2, respectively.  Plasma ghrelin, insulin, glucose, BHBA, NEFA, TG 
and UN concentrations varied largely through time (P < 0.002, Figures 1 and 2), and no 
significance of the interaction time by treatment was observed (P > 0.192).  The time 
effect for plasma ghrelin, glucose and NEFA concentrations was due to a postprandial 
decrease.  Plasma insulin, BHBA, TG and UN concentrations increased after feeding. 
The means of plasma ghrelin concentration were higher (P < 0.001, Table 3) in 
cows fed CLFA compared with cows not fed CLFA.  Compared with cows fed 
Table 2 
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non-CLFA, plasma glucagon and insulin concentrations in cows fed CLFA were lower 
(P = 0.002 and P = 0.012, respectively), and plasma GLP-1 concentration tended to be 
lower (P = 0.061).  Plasma insulin concentration tended to be higher (P = 0.092) in 
cows supplemented RPM than those without RPM.  There were interactions between 
CLFA and RPM for ghrelin and glucagon (P = 0.002 and P = 0.041, respectively): 
CLFA plus RPM increased plasma ghrelin, glucagon, but RPM alone did not show such 
effects. 
Compared to those without CLFA, plasma NEFA, TG, T-Cho and UN 
concentrations in cows fed CLFA were higher (P < 0.001, P = 0.029, P < 0.001, and P < 
0.001, respectively), but with lower plasma BHBA concentration (P = 0.006, Table 3).  
In cows fed RPM diets, plasma glucose concentration was higher (P = 0.001), plasma 
T-Cho concentration was lower (P = 0.009), and plasma NEFA and UN concentration 
tended to be lower (P = 0.15 and P = 0.121, respectively).  Interactions between CLFA 
and RPM were observed for TG and T-Cho (P = 0.049 and P = 0.003, respectively): 
RPM decreased plasma TG and T-Cho concentrations in cows fed CLFA, but did not 
affect the cows not fed with CLFA. 
 
 
Table 3 
Figure 1 
Figure 2 
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4. Discussion 
High fat inclusion in diets reduces fiber digestion, increases fatty acid absorption, 
inhibits abomasal motility [18] and increases gut hormone secretion [19, 20].  
Consequently, DMI tends to be depressed.  CLFA could prevent such negative effects 
on ruminal fermentation and fiber digestibility in lactating cows [21, 22].  However, 
DMI was decreased by CLFA in this study consistent with other reports [23, 24].  RPM 
did not improve such DMI depression by CLFA contrary to results found by Goulas et 
al. [8] who used lactating ewes.  Additionally, Chillard and Doreau [25] observed no 
improvement effect of RPM on DMI of cows fed a fish oil supplemented diet during 
midlactation, although such non-protected fat including high polyunsaturated fatty acids 
could largely inhibit dietary fiber digestion and depress DMI. 
The increase in plasma glucose concentration of cows fed RPM was consistent 
with Berthiaume et al. [26], while inconsistent with Bertics and Grummer [27].  Such 
discrepancies might be explained by the differences in the physiological state of cows 
(mid vs. early lactation) and energy balance.  Plasma NEFA, T-Cho and TG 
concentrations increased by CLFA in the current study has been previously observed in 
cows [19, 28].  On the other hand, RPM in cows fed CLFA decreased plasma T-Cho 
and TG concentrations and tended to decrease plasma NEFA concentration.  Met is a 
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methyl group donor for phosphatidylcholine in dairy cows [29] to enhance plasma 
lipoprotein.  In laboratory animals, casein (a Met-rich protein) or L-Met induced 
hypercholesterolemia in rabbits and rats [30, 31].  In calves, however, high fat diet 
supplemented with L-Met did not increase plasma VLDL concentration [32], and Met 
hydroxyl analog did not affect hepatic TG accumulation in cows [27].  Whether Met 
enhanced VLDL that was not measured in this study is unknown.  On the other hand, 
because Met is converted to taurine in dairy cows, plasma taurine concentration 
increased linearly with an increase of postruminal Met infusion [33].  Taurine 
conjugates with bile acids to become taurocholate in the liver, and promotes lipid 
absorption and cholesterol consumption [34].  Yagasaki et al. [3] showed that dietary 
Met and Gly reduced serum T-Cho and increased fecal sterol excretion in rats.  
Furthermore, Met, as a sulfur amino acid, suppressed serum NEFA and TG 
concentration through the control of hormone-sensitive lipase activity and the 
restoration of lipoprotein lipase activity in peripheral tissues of hepatoma-bearing rats 
[4].  In this study, therefore, suppression of plasma T-Cho, NEFA and TG with CLFA 
plus Met might be induced by enhanced uptake and use of lipids by various tissues. 
The increase in plasma ghrelin concentration of cows fed CLFA is consistent with 
that of rats that ingested some fatty acids [35].  In addition, RPM decreased plasma 
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ghrelin concentration in cows not fed CLFA, whereas CLFA plus RPM compared with 
CLFA alone tended to increase plasma ghrelin concentration.  Thus, only a 
simultaneous inclusion of CLFA and RPM may enhance ghrelin secretion via the 
changes in lipid metabolism.  Ghrelin enhances food intake in both nonruminants [36] 
and ruminants [37, 38].  As a result, we could not find the relationship between plasma 
ghrelin concentration and feed intake in this study.  Since reports on ghrelin responses 
to lipid metabolism in ruminants are limited, further research is desirable. 
Many researchers have reported that high fat supplementation increased GLP-1 
concentration [20, 39, 40].  Litherland et al. [40] demonstrated that abomasal infusion 
of fat increased plasma GLP-1 concentration dependent on dosage.  Compared with 
others, the decrease of plasma GLP-1 concentration with CLFA in this study could be 
attributed to a lessor fat ingestion level of 280 g/d.  GLP-1 plays a role in food intake 
[41] and Relling and Reynolds [20] have reported that dietary fats increased GLP-1 in 
dairy cows.  Additionally, Relling et al. [42] observed that intrajugular infusion of 
GLP-1 tended to decrease DMI in growing wethers.  In this study however, plasma 
GLP-1 concentration was decreased by CLFA, suggesting that GLP-1 did not mediate 
DMI. 
Plasma insulin concentration decreased in cows fed CLFA with decreasing DMI 
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consistent with previous reports [23, 43].  We consider that insulin depression might be 
due to lessor volatile fatty acids (VFA) production caused by decreased DMI.  
Although we did not determine plasma VFA concentrations, CLFA decreased plasma 
BHBA concentration, derived from butyrate by rumen fermentation.  And, we also 
observed that plasma GLP-1 concentration tended to decrease at the same time, 
suggesting decreased GLP-1, which stimulates insulin secretion, may be related to 
insulin depression in cows fed CLFA. 
CLFA also decreased plasma glucagon concentration.  Our result is consistent 
with that of Cummins and Sartin [43], but inconsistent with that of Khorasani and 
Kennelly [44].  In several species, elevated NEFA decreases plasma glucagon 
concentration [45, 46].  However, the present results showed that the decrease of 
plasma glucagon with CLFA was attenuated by RPM.  In our previous study, glucagon 
secretion was more strongly enhanced when amino acids and ghrelin were 
simultaneously administered compared with the administration of ghrelin alone in 
lactating cows [11].  In addition, RPM tended to depress plasma NEFA concentration 
of cows fed CLFA.  Therefore, we consider that increased Met absorption, higher 
plasma ghrelin concentration and a decreased plasma NEFA concentration might 
modulate plasma glucagon depression in CLFA-fed cows.   
16 
 
The present study did not show any favorable effects of RPM on feed intake and 
milk production in cows fed with CLFA although plasma ghrelin concentration 
increased.  Further studies are desirable to elucidate the effects of lactating stage and 
Met supplemental level with CLFA on DMI and milk production. 
In conclusion, responses to CLFA are associated with increases in plasma 
concentration of ghrelin and decreases of insulin, glucagon and GLP-1.  RPM plus 
CLFA modulated plasma lipid concentrations and concomitantly elevated plasma 
ghrelin concentration.  These metabolic and endocrine changes were induced by 
absorbed long-chain fatty acid and methionine and not by energy intake because MEI 
was not different among treatments. 
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Figure captions: 
Figure 1. Plasma hormone (ghrelin: A, GLP-1: B, glucagon: C and insulin: D) 
concentrations in cows fed each treatment diet: non-CLFA + non-RPM (○ with a solid 
line), non-CLFA + RPM (● with a dotted line), CLFA + non-RPM (△ with a solid line), 
and CLFA + RPM (▲ with a dotted line).  Values are expressed as least square of 
means (n=4).  P-value for effects of treatment, time and the interaction between 
treatment and time.  The horizontal bar and arrow show the milking period and feeding 
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time, respectively. 
 
 
Figure 2. Plasma metabolite (glucose: A, BHBA: B, NEFA: C, TG: D, T-Cho: E and 
UN: F) concentrations in cows fed each treatment diet: non-CLFA + non-RPM (○ with 
a solid line), non-CLFA + RPM (● with a dotted line), CLFA + non-RPM (△ with a 
solid line), and CLFA + RPM (▲ with a dotted line).  Values are expressed as least 
square of means (n=4).  P-value for effects of treatment, time and the interaction 
between treatment and time.  The horizontal bar and arrow show the milking period 
and feeding time, respectively. 
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Item Non-CLFA CLFAa
Ingredient (DM basis)
Corn silage (%) 42.2 41.6
  Alfalfa hay cubes (%)    7.60    7.48
  Sudan grass hay (%)    5.68    5.60
  Concentrateb (%) 43.9 43.2
  Calcium salts of fatty acidsc (%)    0.00    1.50
  Calcium Carbonate (%)    0.60    0.60
  Salt (%)    0.01    0.01
  Vitamin premix (%)    0.01    0.01
Chemical composition (DM basis)
  OM (%) 93.0 92.7
  CP (%) 14.1 13.9
  NDF (%) 32.2 31.7
  Crude fat (%)   3.24   4.45
  MEd (Mcal/kg)    2.42    2.48
33% oleic acid, 32% linoleic acid, and 5% linolenic acid.
dMetabolizable energy: Estimated value from NRC (2001).
Table 1. Ingredient and chemical composition of the diets
aLCFA: Calcium salts of long-chain fatty acids.
bConcentrate contained 39% corn grain, 17% corn gluten feed, 16% beet pulp pel
10% soybean meal,6% canola meal, 5% wheat middlings, 5% wheat bran, 2% mo
cMegalac R: Declared fatty acids contained 26% palmitic acid, 4% stearic acid,
Table 2. Feed intake, milk production and composition during experimental period in lactating cows
Item non-RPM RPM non-RPM   RPMb SEM CLFA  RPM CLFA × RPM
DMI (kg/d) 22.4 22.2 21.3 21.7   0.675 0.025 0.803 0.322
MEId (Mcal/d) 56.7 56.2 55.4 56.4 1.72 0.463 0.794 0.325
Milk yield (kg/d) 27.2 27.1 27.3 27.5 1.83 0.508 0.982 0.655
4% FCMe (kg/d) 29.9 28.8 30.0 30.3 1.63 0.505 0.766 0.574
Milk composition
Fat (%)    4.46    4.35    4.48    4.42 0.44 0.825 0.685 0.909
Protein (%)    3.51    3.56    3.47    3.45   0.132 0.177 0.729 0.508
Lactose (%)    4.62    4.59    4.61    4.61   0.059 0.736 0.743 0.662
Total solid (%) 13.6 13.5 12.7 12.5 1.01 0.107 0.759 0.966
Solid non-fat (%)    9.13    9.11    9.08    9.11   0.124 0.736 0.973 0.710
Body weight changes (kg) 14.3 18.5 13.5 12.7 4.60 0.359 0.612 0.474
e4% FCM: 4% fat corrected milk (kg/d) = 0.4 × Milk yield (kg/d) + 15 × Milk yield (kg/d) × Milk fat (%).
Data are shown by least squares means (LSM) and SEM.
aCLFA: Calcium salts of long-chain fatty acids.
bRPM: Rumen-protected methionine.
cP -value for factorial contrasts: CLFA, RPM and the interaction between CLFA and RPM.
dMEI: Metabolizable energy intake.
Treatment
         non-CLFA      CLFAa          Contrastc (P -value)
Item non-RPM RPM non-RPM  RPMb SEM   CLFA RPM CLFA × RPM
Hormones
  Ghrelin (ng/mL)        0.106      0.087      0.116      0.126       0.027      <0.001 0.301 0.002
  GLP-1d (ng/mL)       0.519      0.464     0.452      0.448      0.128 0.061 0.185 0.258
  Glucagon (pg/mL) 99.1 93.6 60.3 85.5 46.2 0.002 0.187 0.041
  Insulin (ng/mL)    2.51    2.86 2.36    2.41      0.128 0.012 0.092 0.202
Metabolites
  Glucose (mg/dL) 62.9 63.4 62.1 63.6    1.91 0.872 0.001 0.344
  BHBAe (μmol/L)       595       579       514       517 43.4 0.006 0.796 0.729
  NEFA (μEq/L) 95.4 90.2       116       110    7.13      <0.001 0.150 0.842
  TGf (mg/dL)    7.57    8.29    9.86    8.41    0.82 0.029 0.501 0.049
  T-Chog (mg/dL)       197       200       247       211 14.9      <0.001 0.009 0.003
  UNh (mgN/dL)     8.79    8.13    9.26    9.23    0.70      <0.001 0.121 0.152
dGLP-1: Glucagon-like peptide-1 (7-36) amide.
fTG: Triglyceride
gT-Cho: Total-cholesterol.
hUN = Urea nitrogen.
Data are shown by least squares means (LSM) and SEM.
aCLFA: Calcium salts of long-chain fatty acids.
bRPM: Rumen-protected methionine.
cP -value for factorial contrasts: CLFA, RPM and the interaction between CLFA and RPM.
eBHBA: β-hydroxy butyrate.
Table 3. Plasma hormone and metabolite concentrations during feeding period in lactating cows
Treatment
     non-CLFA     CLFAa Contrastc (P -value)
